#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Bronchopulmonary dysplasia Bile acid synthesis disorder Henoch-Schonlein purpura nephritis Medulloblastoma recurrent Uveal melanoma Pericarditis Emphysema Thrombocytosis Chondrodystrophy Ependymoma Small cell lung cancer recurrent Antithrombin III deficiency Marginal zone lymphoma Post transplant lymphoproliferative disorder Atopic keratoconjunctivitis More trials…

    Learn about Rare Diseases

    Hereditary angioedema – Basic Information Amyotrophic lateral sclerosis – Life with Disease Mucopolysaccharidosis I Marginal zone lymphoma refractory – Basic Information Mastocytosis – Treatment Factor VIII deficiency – Life with Disease Hairy cell leukaemia recurrent – Diagnostics Alagille syndrome – Basic Information Nodal marginal zone B-cell lymphoma Haemolytic uraemic syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tovorafenib Omaveloxolone Fluorescein Sodium Anitocabtagene Autoleucel Specific Nucleic Acid Sna-Xfsa Pp1493 Selinexor Utreloxastat Chloropyramine Hydrochloride Olodaterol Argipressin Perindopril Tert-Butylamine Tolcapone Kyv-101 Pegcetacoplan Medroxyprogesterone Acetate Dmd06-Mab Nivolumab Tusamitamab Ravtansine Ondansetron More therapies…

    Learn about Your Condition

    Bronchiolitis Myofascial pain syndrome Lichen sclerosus Agitation Procedural hypotension Polymyalgia rheumatica Hand dermatitis Metabolic syndrome Lysosomal storage disorder Syphilis Chondroplasty Pancreatic failure Thrombotic microangiopathy Anal fistula Macular degeneration More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Type 1 diabetes mellitus

  • Safety and Pharmacokinetic Dose-Escalation Study of IMC-S118AI and Sodium Chloride in HLA‑A*02:01‑Positive Participants with Type 1 Diabetes

    Recruiting

    1 1 1
    Investigated Drugs:
    • Sodium Chloride
    Austria

  • Using glucagon and automated insulin delivery to prevent low blood sugar during exercise in adults with type 1 diabetes

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Glucagon
    • Dasiglucagon
    Denmark

  • Study of Colchicine to Reduce Complications in People with Type 1 Diabetes and High Blood Sugar Variability

    Recruiting

    3 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Colchicine
    The Netherlands

  • Study of IMMUNOSTEM gene therapy using modified stem cells for newly diagnosed patients with type 1 diabetes who still produce insulin

    Recruiting

    2 1 1
    Investigated Drugs:
    • IMMUNOSTEM
    Italy

  • Study of colchicine to improve insulin sensitivity in adults with type 1 diabetes who have low-grade inflammation

    Recruiting

    2 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Opium, Standardized Powdered
    • Tiemonium Methylsulphate
    • Colchicine
    Denmark

  • Study of semaglutide for weight loss in adults with type 1 diabetes and obesity

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    • Obesity
    Investigated Drugs:
    • Placebo
    • Semaglutide
    Denmark
1 2 3 … 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!